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Introduction 
In 1992, the Centers for Disease Control and Prevention 
(CDC) defined idiopathic CD4’ T-lymphocytopaenia 
(ICL) as a reproducible CD4’ lymphocytopaenia 
(~300 mm- 3, in the absence of human immunodeficiency 
virus (HIV) infection or other known cause of immuno- 
deficiency (1). Ten of the 47 patients with ICL reported by 
Smith and coworkers developed opportunistic pulmonary 
infections (2), and only three cases of pulmonary tubercu- 
losis were found. On the other hand, CD4’ T-lymphocyte 
level is occasionally reported to be reduced in various 
infectious diseases including pulmonary tuberculosis (3,4). 
Case Report 
A 49-year-old man was admitted to a local hospital in 
March 1993 because of fever and increasing dyspnoea. He 
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had been well until 1 month prior to admission. He had 
no risk factors and had never taken immunosuppressive 
therapy. A chest roentgenogram on admission showed 
reticulonodular shadows (2-5 mm) distributed throughout 
both lungs with a pleural effusion in the left chest (Plate 1). 
Arterial blood gas analysis on room air showed severe 
hypoxaemia with a respiratory alkalosis (PaO,=4.64 kPa, 
PaCO,=3,31 kPa, and pH=7.50). Although antibiotics 
were administered, his hypoxaemia progressively worsened 
and he developed acute respiratory failure. Three days later, 
he was transferred to our hospital. On physical examination 
the patient appeared acutely ill, and dyspnoeic. There was 
severe lip and peripheral cyanosis. Inspiratory crackles were 
heard over both lungs. He required mechanical ventilation 
due to severe hypoxaemia. 
Laboratory studies revealed a white blood cell count of 
12200mm-3 (lymphocytes; 3%). The CD4’ cell count 
was 5lmm-’ and the CD8’ cell count 181 mm-’ (a 
CD4:CD8 ratio of 0.28) (Fig. 1). Serum immunoglobulin 
levels were normal except for a slightly low IgM level. A 
sputum smear was positive for acid-fast bacilli and subse- 
quently grew colonies (2040) of Mycobacterium tuberculo- 
sis on culture. A skin test with purified protein derivative 
was negative. Serological tests for HIV-l and HIV-2 anti- 
bodies were negative as determined by both ELISA and 
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FIG. 1. Time course of lymphocyte, CD4+, and CD8+ 
cell counts. With antituberculous treatment, CD4+ cell 
counts remained less than 300 mm- 3 except on one 
occasion, although lymphocyte and CD8’ cell counts 
recovered. 
Western blot. Antibody to human T-cell lymphotrophic 
virus Type 1 was also not detected. He was diagnosed 
as having miliary tuberculosis and idiopathic CD4’ 
T-lymphocytopaenia. He was begun on antituberculous 
chemotherapy: isoniazid, rifampicin, ethambutol and 
streptomycin sulfate, plus oral kanamycin. 
The M. tuberculosis organisms isolated were sensitive 
to these antituberculous drugs. He had a good response to 
this regimen and his hypoxaemia gradually improved. On 
chest roentgenogram reticulonodular shadows gradually 
cleared. However, the CD4+ cell count and CD4:CD8 ratio 
remained low (Fig. 1). He was discharged from hospital in 
December 1993. In August of 1994, the CD4+ cell count 
was 247 mm - 3, the CD8’ cell count was 804 mm- 3 and 
the CD4:CDS ratio was 0.31. Repeated HIV tests were 
negative. His clinical status remains unchanged at time of 
writing. 
Discussion 
In pulmonary tuberculosis with acquired immune deficiency 
syndrome (AIDS), the roentgenographic pattern of primary 
tuberculosis and postprimary tuberculosis was observed in 
64% of the patients and that of a miliary pattern was 3% 
(5). In ICL, however, the clinical picture of pulmonary 
tuberculosis is poorly understood. In a review by Smith and 
coworkers (2) pulmonary tuberculosis was found in only 
three patients. To our knowledge, acute respiratory failure 
due to miliary tuberculosis in ICL has not been previously 
reported. This patient had no prior history of pulmonary 
tuberculosis. However, on a chest roentgenogram taken 
several years prior to admission, several calcified nodules 
and pleural thickening of the right apex were observed, 
suggesting that he may have had primary pulmonary 
tuberculosis. It is likely that suppression of cell-mediated 
immunity by ICL may reactivate a site of old tuberculosis, 
resulting in miliary tuberculosis. The patient likely acquired 
PLATE 1. Chest roentgenogram on admission. Reticulo- 
nodular shadows are diffusely distributed in both lungs, 
especially in the upper and middle lung fields of the 
left lung. 
pulmonary tuberculosis, because in Japan the morbidity of 
pulmonary tuberculosis is still high, three or more times 
that in the U.S.A. or the U.K. (6). 
It has been reported that pulmonary tuberculosis is 
occasionally linked to deletion of CD4’ T-lymphocytes, 
usually within the low normal range (4). In our patient, the 
CD4’ cell count on admission was extremely low, compar- 
able to the values in ICL patients reported by Smith and 
coworkers (2). Effective antituberculous treatment is re- 
ported to normalize tuberculous CD4’ T-lymphocytopaenia 
(7). After 6 months of antituberculous treatment, our 
patient clinically and radiographically improved, but the 
CD4’ cell count remained below 300 mm- 3 (Fig. 1). 
However, total lymphocyte and CD8’ cell counts were 
initially decreased, and returned to the normal range within 
1 month. CD8’ T-lymphocytopaenia (~250 cells mm- 3, is 
observed in some patients with ICL (2,8). In pulmonary 
tuberculosis without HIV infection, CD8’ cell counts can 
be decreased similar to CD4’ cells, preserving a normal 
CD4:CD8 ratio (3,7). With antituberculous treatment, both 
CD4’ and CD8’ cell counts usually normalize (7). In our 
patient, CD8’ cell counts were low on admission, and with 
antituberculous treatment, CD8+ cell counts recovered, 
while CD4’ cell counts remained low, preserving the low 
CD4:CD8 ratio. 
CD4+ T-lymphocyte depletion in the absence of HIV 
infection is known to occur in certain bacterial, viral and 
fungal infections, lymphoproliferative disorders and auto- 
immune disorders (3,7,9). Our patient had no evidence 
of any of these conditions, and had never received any 
immunosuppressive drug. We cannot find any cause for 
this patient’s CD4’ T-lymphocyte depletion, including 
HIV infection. Thus, our patient with idiopathic CD4+ 
T-lymphocytopaenia had suffered from miliary tuberculosis 
with acute respiratory failure. 
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Introduction 
Pulmonary veno-occlusive disease (PVOD) is a rare condi- 
tion in which the predominant anomaly is the stenosis or 
occlusion of the lumen of small pulmonary veins due to 
fibrosis of the intima (1). Its aetiology is unknown, 
although it is sometimes associated with viral infection, 
environmental toxins, chemotherapy, autoimmune disease, 
use of contraceptives, intracardiac shunts or radiation 
injury, and some cases suggest genetic predisposition (2). In 
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spite of a variety of therapies having been tried, it is usually 
fatal within a few years; lung transplant is currently the 
treatment of choice. Its definitive diagnosis requires dem- 
onstration of the above-mentioned anatomopathological 
features in pulmonary biopsy material, although pulmon- 
ary biopsy is not always possible. The diagnostic difficulties 
associated with three cases of PVOD seen in our centre in 
recent years have led us to examine what clinical criteria 
constitute sufficient grounds for carrying out pulmonary 
biopsy to confirm PVOD. 
Case Reports 
For all three patients, cardiac and pulmonary circulation 
parameters measured by cardiac catheterization are listed in 
Table 1, and pulmonary function parameters in Table 2. 
